The adjunctive use of methylmethacrylate in fixation of pathological fractures.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000150:complications / Q000628:therapy; D001943:Breast Neoplasms / Q000473:pathology; D002812:Chondroma / Q000473:pathology; D005260:Female; D005264:Femoral Fractures / Q000628:therapy; D005593:Fracture Fixation, Internal; D005598:Fractures, Spontaneous / Q000401:mortality / Q000517:prevention & control; D005870:Giant Cell Tumors / Q000473:pathology; D006615:Hip / Q000473:pathology; D006801:Humans; D006810:Humeral Fractures / Q000628:therapy; D007680:Kidney Neoplasms / Q000473:pathology; D008297:Male; D008768:Methylmethacrylates / Q000009:adverse effects*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D059408:Pain Management; D013978:Tibial Fractures / Q000628:therapy; D014458:Ulna Fractures / Q000628:therapy
D008768:Methylmethacrylates